Title for MeetingAbstracts
Alphabetical listing of titles
-
Coverage policies for growth hormone: a national study.
-
Coverage, adherence, and sustainability of antiretroviral therapy among injection drug users in Vancouver, Canada.
-
Coverage, Adherence, and Sustainability of Antiretroviral Therapy among Injection Drug Users in Vancouver, Canada.
-
Covert infection of CD4+ lymphocytes and macrophages in lymph nodes of HIV-infection demonstrated by a polymerase chain reaction (PCR)-in situ method.
-
Cowboys, condoms and complacency.
-
Cowpea harvest scenarios and edible biomass production under controlled environments.
-
COX-2 induction by gp-120 in neuroblastome cells.
-
Coxiella burnetii (Q fever) Seropositivity is Associated with Adverse Pregnancy Outcomes.
-
Coxsackievirus as a Vector for a Therapeutic HIV Vaccine.
-
CP 5068, a New Carbapenem: In Vitro and In Vivo Activities against Penicillin-Resistant Streptococcus pneumoniae.
-
CP5068, a New Carbapenem: In Vitro and In Vivo Activities against MRSA.
-
CP5068, a New Carbapenem: Synthesis and Structure-Activity Relationships.
-
CP5609, a Novel Parenteral Carbapenem: Efficacy on Experimental Endocarditis due to Methicillin-Resistant Staphylococcus aureus.
-
CP5609, a Novel Parenteral Carbapenem: Efficacy on Rabbit Endocarditis Due to Methicillin-Resistant Staphylococcus aureus.
-
CP5609, a Novel Parenteral Carbapenem: Efficacy on Rabbit Meningitis Due to Penicillin-Resistant Streptococcus pneumoniae.
-
CP5609, a Novel Parenteral Carbapenem: In Vitro Activities against Methicillin-Resistant S. aureus, Penicillin-Resistant S. pneumoniae and beta-lactamase Negative Ampicillin-Resistant H. influenzae.
-
CP5609, a Novel Parenteral Carbapenem: In Vivo Activities against Methicillin-Resistant S. aureus, Penicillin-Resistant S. pneumoniae and beta-lactamase Negative Ampicillin-Resistant H. influenzae.
-
CP5609, a Novel Parenteral Carbapenem: Pre-Clinical Toxicological Profile.
-
CP5609, a Novel Parenteral Carbapenem: Synthesis and Structure-Activity Relationships.
-
CPCRA 064: A Randomized Trial Examining Structured Treatment Interruption for Patients Failing Therapy with Multi-drug Resistant HIV.
-
CPCRA seminars: a model for involvement of patients in community based clinical research.
-
CPCRA/CBCTN observational data base project: a major community-based research project on HIV infection.
-
CPDA-Anticoagulated Blood from the Blood Transfusion Center (BTC) Provides a Reliable Method for Detecting Inflammatory Components from Gram+, but not Gram- Bacteria.
-
CPG 101: Back to the Basics for Young Adults.
-
CpG 7909 Administered with Hepatitis B Vaccine to HIV-infected Individuals Induces Helper Cell Responses to Hepatitis B Surface Antigen, but Not HIV Antigen.
-
CPG Development -- an international comparison.
-
CpG DNA significantly enhances mucosal immune responses and protection against viral infection in the genital tract.
-
CpG immuno stimulatory oligodeoxynucleotides overcome a Th2 biased immune response for the generation of Th1 HIV-1 specific immunity.
-
CpG Overcomes the Th2 Biased Immune Profile in Schistosoma-Infected Mice to Generate Th1 Type HIV-1-Specific Immune Responses to Remune-Relevance to AIDS Vaccines in Developing Countries.
-
CpG Stimulation of Interferon-gamma Production In Vitro is Modified by IL-10 and B-cells.